http://www.mersana.com
Mersana Therapeutics, Inc. Company Intro
Technology Mersana has developed highly differentiated and innovative antibody-drug conjugate (ADC) platforms, with both cytotoxic and immunostimulatory payloads, that allow for customization and optimization of ADCs for a given target and indication. As a result, we are designing ADCs to overcome the limitations of first-generation platforms by delivering therapeutics with greater efficacy and tolerability to […]
Industry
Healthcare
Mersana Therapeutics, Inc. Headquaters
840 Memorial Drive
Cambridge,02139
United States
Mersana Therapeutics, Inc. Share price
14 Sep 2022 09:47 GMT
$7.43
-0.05 (-0.67 %)
Mersana Therapeutics, Inc. Market cap
$525.675 M
WMC RANKING
2022
Mersana Therapeutics, Inc. # 271
BiotechnologyLatest Mersana Therapeutics, Inc. News
04 Dec 2022
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Stock Position ...
Mersana Therapeutics, Inc is a clinical-stage biopharmaceutical company, which focuses on developing antibody drug conjugates that offer clinical benefit for...
03 Dec 2022
Mersana Therapeutics Inc. (NASDAQ: MRSN) Could shrink By ...
Mersana Therapeutics Inc. (NASDAQ:MRSN)'s traded shares stood at 0.85 million during the last session, with the company's beta value hitting 1.66.
02 Dec 2022
Cancer stocks languish amid challenging markets
Mersana Therapeutics Inc.'s stock (NASDAQ:MRSN) is one of the two BCI stocks that is above water this year. Shares are up 8.8%.
WMC Market Score
WMC Market to Revenue Score
Mersana Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Mersana Therapeutics, Inc. | USD | $828 | $106,406 | $-105,812 | $5,257M | 271 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Mersana Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Mersana Therapeutics, Inc. Post vs Top 4 Industry Competitors
Mersana Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Mersana Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Mersana Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Mersana Therapeutics, Inc. | 0.01 | 2.42 | 27.71 | 0 | 0 | 0 | 13.59 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
